Indications and uses
helps prevent sunburn
SPF30+ SUMMER BLEND™ SUNSCREEN LOTION
- Manufacturer
- ORGANIC & SUSTAINABLE BEAUTY
- Effective date
- 2024-11-07
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 00:35:43
Label at a glance#
ProductSPF30 SUMMER BLEND SUNSCREEN
Active ingredientTITANIUM DIOXIDE
Label structure9 sections
Dosage and administration
Apply liberally 30 minutes before sun exposure Reapply – after 80 minutes of swimming or sweating immediately after towel drying – at least every 2 hours Children under 6 months: ask a doctor Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protect...
Storage and handling
protect the product in this container from excessive heat and direct sunlight report serious adverse reactions to: 5933 Bowcroft St. Los Angeles, CA 90016
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active ingredient
Titanium Dioxide 12%
Purpose
Sunscreen
Uses
- helps prevent sunburn
Warnings
For external use only.
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs.
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally 30 minutes before sun exposure
- Reapply – after 80 minutes of swimming or sweating immediately after towel drying – at least every 2 hours
- Children under 6 months: ask a doctor
- Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including – limit time in the sun, especially from 10 a.m. - 2 p.m. – wear long-sleeved shirts, pants, hats and sunglasses
Other information
- protect the product in this container from excessive heat and direct sunlight
- report serious adverse reactions to: 5933 Bowcroft St. Los Angeles, CA 90016
Inactive ingredients
Water, c12-15 alkyl benzoate, coco-caprylate, glycerin, polyhydroxystearic acid, caprylic/capric triglyceride, polyglyceryl-2 dipolyhydroxystearate, candelilla cera, cocos nucifera (coconut) oil, tapioca starch, polyglyceryl-3 diisostearate, rosmarinus officinalis (rosemary) leaf extract, squalane, allantoin, panthenol, magnesium stearate, sodium levulinate, cymbopogon nardus oil, cymbopogon schoenanthus oil, cedrus atlantica wood oil, caprylhydroxamic acid, glyceryl caprylate.
PRINCIPAL DISPLAY PANEL - 82 g Tube Label
CALIFORNIA BABY®
TRUSTED SINCE 1995
summer blend™
30+
SUNSCREEN LOTION
HIGH PROTECTION
GET OUTDOORSY WITH IT
BROAD SPECTRUM
SPF 30+ SUNSCREEN
WATER RESISTANT (80 MINUTES)
FOR BABIES, KIDS + ADULTS
WITH SENSITIVE SKIN
ALLERGY
TESTED
© 2018
NET WT 82 g/2.9 oz.
BLENDED, MANUFACTURED & PACKAGED IN OUR FDA REGISTERED & CERTIFIED ORGANIC U.S.A. FACILITY
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52915-040-29 | 2020-11-04 | C162847 | 48780-1 | 9855d018-d7e1-cd31-e053-dbdaa90ab51a | SPF30+ SUMMER BLEND™ SUNSCREEN LOTION |
| 52915-040-29 | 2019-11-27 | C162847 | 48780-1 | 9855d018-d7e1-cd31-e053-dbdaa90ab51a | SPF30+ SUMMER BLEND™ SUNSCREEN LOTION |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52915-040-29 | SPF30 SUMMER BLEND SUNSCREEN | 82 g in 1 TUBE | LOTION/SHAMPOO | 82 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| alkyl (c12-15) benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| allantoin | INACTIVE INGREDIENT | 344S277G0Z | 1 | |
| candelilla wax | INACTIVE INGREDIENT | WL0328HX19 | 1 | |
| caprylhydroxamic acid | INACTIVE INGREDIENT | UPY805K99W | 1 | |
| carthamus tinctorius seed oleosomes | INACTIVE INGREDIENT | 9S60Q72309 | 1 | |
| cedrus atlantica bark oil | INACTIVE INGREDIENT | ZX5QRE4U60 | 1 | |
| citronella oil | INACTIVE INGREDIENT | QYO8Q067D0 | 1 | |
| coco-caprylate | INACTIVE INGREDIENT | 4828G836N6 | 1 | |
| coconut oil | INACTIVE INGREDIENT | Q9L0O73W7L | 1 | |
| cymbopogon schoenanthus oil | INACTIVE INGREDIENT | XE7K568ILO | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| glyceryl caprylate | INACTIVE INGREDIENT | TM2TZD4G4A | 1 | |
| levulinic acid | INACTIVE INGREDIENT | RYX5QG61EI | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| medium-chain triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| panthenol | INACTIVE INGREDIENT | WV9CM0O67Z | 1 | |
| polyglyceryl-2 dipolyhydroxystearate | INACTIVE INGREDIENT | 9229XJ4V12 | 1 | |
| polyglyceryl-3 diisostearate | INACTIVE INGREDIENT | 46P231IQV8 | 1 | |
| polyhydroxystearic acid (2300 MW) | INACTIVE INGREDIENT | YXH47AOU0F | 1 | |
| rosemary | INACTIVE INGREDIENT | IJ67X351P9 | 1 | |
| squalane | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| starch, tapioca | INACTIVE INGREDIENT | 24SC3U704I | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- SPF30 SUMMER BLEND SUNSCREEN
- TITANIUM DIOXIDE
- Water
- alkyl (c12-15) benzoate
- carthamus tinctorius seed oleosomes
- coco-caprylate
- glycerin
- polyhydroxystearic acid (2300 MW)
- medium-chain triglycerides
- polyglyceryl-2 dipolyhydroxystearate
- candelilla wax
- coconut oil
- starch, tapioca
- polyglyceryl-3 diisostearate
- rosemary
- squalane
- allantoin
- panthenol
- magnesium stearate
- levulinic acid
- citronella oil
- cymbopogon schoenanthus oil
- cedrus atlantica bark oil
- caprylhydroxamic acid
- GLYCERYL MONOCAPRYLATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 52915-040 | 52915-040-29 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| squalane | SQUALANE | GW89575KF9 | CREAM, AUGMENTED / TOPICAL | 120 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | GEL / TOPICAL | 12 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| glyceryl caprylate | GLYCERYL MONOCAPRYLATE | TM2TZD4G4A | CAPSULE / ORAL | 400 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| squalane | SQUALANE | GW89575KF9 | SOLUTION / TOPICAL | 1 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| coconut oil | COCONUT OIL | Q9L0O73W7L | SOAP / TOPICAL | 4.6 %w/w | ||
| allantoin | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | OINTMENT / TOPICAL | 20 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CREAM / TOPICAL | 3300 mg | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| levulinic acid | LEVULINIC ACID | RYX5QG61EI | SYSTEM / TRANSDERMAL | 20 mg | ||
| starch, tapioca | STARCH, TAPIOCA | 24SC3U704I | CAPSULE / ORAL | 100 mg | ||
| squalane | SQUALANE | GW89575KF9 | CREAM / TOPICAL | 6 %w/w | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | AEROSOL, FOAM / TOPICAL | 10.87 %w/w | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | LOTION / TOPICAL | 7 %w/w | ||
| coconut oil | COCONUT OIL | Q9L0O73W7L | SOAP / TOPICAL | 4.6 %w/w | ||
| squalane | SQUALANE | GW89575KF9 | AEROSOL, FOAM / TOPICAL | 2.23 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CREAM / TOPICAL | 3300 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| squalane | SQUALANE | GW89575KF9 | CREAM, AUGMENTED / TOPICAL | 120 mg | ||
| candelilla wax | CANDELILLA WAX | WL0328HX19 | TABLET, EXTENDED RELEASE / ORAL | 3 mg | ||
| coconut oil | COCONUT OIL | Q9L0O73W7L | SOLUTION / TOPICAL | 15.5 %w/w | ||
| levulinic acid | LEVULINIC ACID | RYX5QG61EI | FILM, EXTENDED RELEASE / TRANSDERMAL | 16.5 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| squalane | SQUALANE | GW89575KF9 | AEROSOL, FOAM / TOPICAL | 2.23 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| candelilla wax | CANDELILLA WAX | WL0328HX19 | TABLET, DELAYED RELEASE / ORAL | 1 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| magnesium stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| candelilla wax | CANDELILLA WAX | WL0328HX19 | TABLET, FILM COATED / ORAL | 0.8 mg | ||
| coconut oil | COCONUT OIL | Q9L0O73W7L | OINTMENT / TOPICAL | 14.75 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| candelilla wax | CANDELILLA WAX | WL0328HX19 | TABLET, EXTENDED RELEASE / ORAL | 3 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | OINTMENT / TOPICAL | 20 %w/w | ||
| glyceryl caprylate | GLYCERYL MONOCAPRYLATE | TM2TZD4G4A | TABLET / ORAL | 1 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| levulinic acid | LEVULINIC ACID | RYX5QG61EI | FILM, EXTENDED RELEASE / TRANSDERMAL | 16.5 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SPRAY / TOPICAL | 540 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | AEROSOL, FOAM / TOPICAL | 10.87 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| allantoin | ALLANTOIN | 344S277G0Z | GEL / TOPICAL | 8 mg | ||
| medium-chain triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | GEL / TOPICAL | 12 mg | ||
| glyceryl caprylate | GLYCERYL MONOCAPRYLATE | TM2TZD4G4A | CAPSULE / ORAL | 400 mg | ||
| candelilla wax | CANDELILLA WAX | WL0328HX19 | TABLET / ORAL | 4 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| candelilla wax | CANDELILLA WAX | WL0328HX19 | TABLET, DELAYED RELEASE / ORAL | 1 mg | ||
| candelilla wax | CANDELILLA WAX | WL0328HX19 | TABLET / ORAL | 4 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SPF30 SUMMER BLEND SUNSCREEN | TITANIUM DIOXIDE | ORGANIC & SUSTAINABLE BEAUTY | 9641b71a-81f2-4157-801b-162188392a91 | 2024-11-07 | Warnings | 52915-040-29 52915-040 52915004029 33f43ddf-e9c7-4f3f-b030-939d4833be94 9641b71a-81f2-4157-801b-162188392a91 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.